Crossmark

Refractory Dermatomyositis Treated With Anifrolumab: Clinical Response and Dynamics of Type-I Interferon Signature

Crossref DOI link: https://doi.org/10.1016/j.ad.2026.104679

Published Print: 2026-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gimeno-Ribes, M.E. https://orcid.org/0000-0002-6362-0333
Mensa-Vilaro, A.

Aróstegui, J.I.

Prieto-González, S.

Milisenda, J.C.

Bosch-Amate, X.

Mascaró, J.M. Jr.
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III

European Commission
License Information

Text and Data Mining valid from 2026-10-01

Text and Data Mining valid from 2026-10-01

Version of Record valid from 2026-05-15
More Information

This article is maintained by: Elsevier

Article Title: Refractory Dermatomyositis Treated With Anifrolumab: Clinical Response and Dynamics of Type-I Interferon Signature

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2026.104679

Content Type: simple-article

Copyright: © 2026 Published by Elsevier España, S.L.U. on behalf of AEDV.